What Is Benzisothiazolinone and Is It Safe?

Benzisothiazolinone, usually abbreviated BIT, is a synthetic preservative used to kill bacteria and fungi in an enormous range of everyday products, from house paint to dishwashing liquid to paper food packaging. For most people at typical exposure levels, it does not pose a serious health threat. The safety concern that has grabbed researchers’ attention over the past decade is skin sensitization: the rate of allergic contact reactions to BIT has climbed sharply, and dermatologists in several countries now flag it as an emerging allergen worth watching.

What BIT Actually Is

BIT belongs to a family of chemicals called isothiazolinones, which share a ring-shaped molecular core containing sulfur and nitrogen. That core is what makes them effective at disrupting microbial cell membranes and interfering with enzymes that bacteria and fungi need to survive. You have probably encountered other members of the family without realizing it: methylisothiazolinone (MI) and a combination called MCI/MI were the go-to preservatives in cosmetics and cleaning products for decades before regulators started restricting them in the 2010s. BIT stepped into the gap as manufacturers looked for alternatives, which is partly why it now shows up so widely.

The chemical is water-soluble, breaks down relatively quickly in the environment compared to some persistent biocides, and works at low concentrations. Those traits make it attractive for industrial use. It also has no strong odor or color at the concentrations used in consumer goods, so it can be added without changing a product’s look or smell.

Where You Run Into It

Paint is the single biggest source of BIT exposure for most people. A study of 71 paints from five European countries found BIT in nearly 96% of samples, at concentrations ranging from trace amounts up to about 460 parts per million (ppm).¹ Paints purchased in Scandinavia tended to have especially high BIT levels. Beyond paint, analytical testing of consumer products labeled as containing BIT found concentrations up to 272 ppm in non-cosmetic items like household cleaners.²

The list of product categories goes well beyond paint and cleaners. BIT turns up in:

• Adhesives: consumer glues and tapes have been found to contain various isothiazolinones, including BIT.³
• Paper food packaging: researchers have developed methods to detect BIT and related biocides in paper meant for food contact.⁴
• Cosmetics and personal care products: shampoos, lotions, and liquid soaps sometimes list it on the label, though concentrations tend to be lower than in household or industrial products.
• Industrial metalworking fluids and cooling systems: BIT is added to prevent microbial fouling in water-based industrial systems.

One complication with BIT is that labeling can be spotty. In the European study of consumer products, researchers found isothiazolinones in some hobby paints that did not declare them on the label at all.² If you are trying to avoid it because of a known sensitivity, reading labels alone may not be enough, especially for non-cosmetic products where ingredient disclosure requirements are less strict than for cosmetics.

The Rise in Allergic Reactions

The main safety issue with BIT is that it can trigger allergic contact dermatitis in susceptible people. This is not an irritant burn from a harsh chemical; it is a genuine immune-mediated response. Once your immune system learns to recognize BIT as a threat, any future skin contact can produce an itchy, red, sometimes blistering rash. The reaction tends to show up 24 to 72 hours after exposure, which makes it tricky to identify the cause.

What concerns dermatologists is how quickly the problem has grown. A large retrospective study at a Belgian hospital tracked patch-test results over more than a decade and found that BIT sensitization rose from about 0.4% of tested patients in 2010 to 3.7% in 2019, before declining somewhat to 0.7% in 2022.⁵ A separate analysis of contact allergy trends from 2014 to 2023 found an even steeper climb, with BIT positivity rising from around 0.3% to 5% over that period.⁶ These numbers represent patients referred to dermatology clinics for suspected contact allergies, so they overestimate the rate in the general population. Still, the upward trajectory is striking and mirrors the pattern seen with MI a decade earlier.

A probabilistic risk assessment that combined product-use surveys with actual BIT concentrations in Swiss household and personal-care products estimated that roughly 1% of the Swiss population may be at risk of becoming sensitized through everyday exposure to BIT in cosmetics and household chemicals.⁷ The main contributors to dermal exposure were all-purpose cleaners, dishwashing detergent, and kitchen cleaner.

Cross-Reactivity With Other Isothiazolinones

If you already react to one isothiazolinone, you might assume you will react to all of them. The reality is more nuanced. Laboratory studies using a modified lymph node assay showed that animals sensitized to MI could cross-react with both BIT and octylisothiazolinone (OIT) when challenged at appropriate concentrations, which suggests the immune system can sometimes recognize structural similarities among the family members.⁸

In clinical practice, though, the overlap between MI and BIT allergies is less straightforward than you might expect. A study of patients who tested positive to OIT found that 89% of them also reacted to MI, but among BIT-positive patients, only about a third also reacted to MI. BIT reactions, in other words, tended to be independent.⁹ Another investigation retested MI-sensitized individuals and found that only one out of seven strongly MI-sensitive patients cross-reacted to BIT, while five of seven cross-reacted to OIT.¹⁰

The practical takeaway: if you know you are allergic to MI (the isothiazolinone most commonly tested for), you should be cautious about BIT but not assume you will definitely react. Cross-reactivity exists but is less frequent than the MI-OIT overlap. Patch testing for BIT specifically is the only reliable way to know whether you personally react to it.

How BIT Gets Through Your Skin

One reason BIT can trigger sensitization even at low concentrations is that it absorbs efficiently through the skin. A pharmacokinetic study in rats found that BIT applied to the skin had about twice the bioavailability of the same dose given orally. The difference comes from bypassing the liver’s first-pass metabolism: when BIT enters through the skin, it reaches the bloodstream more intact. The body eventually breaks it down and clears it through urine, but the higher initial systemic exposure from dermal absorption matters for allergy risk.¹¹

This is not a concern unique to BIT. Many small, water-soluble molecules pass through skin fairly readily. But it does underscore why products that sit on your skin, like lotions or rinse-off cleaners that contact your hands, can deliver meaningful doses even when the BIT concentration is low. It also helps explain why occupational exposure through paint handling is a recurring theme in the sensitization literature.

Occupational and Airborne Exposure

Professional painters have drawn particular attention because they handle BIT-containing products daily, often in poorly ventilated spaces. A Swedish study of painters found that BIT was the isothiazolinone most frequently causing positive patch-test reactions in that group. Painters also reported higher rates of adult-onset eczema than a control group of electricians, although the difference just missed statistical significance.¹²

You do not need to be a professional painter to be affected, either. Airborne allergic contact dermatitis from isothiazolinones in water-based paints has been documented as a recognized health hazard.¹³ When paint dries or is sprayed, volatile biocide particles become airborne and can land on exposed skin anywhere on the body, not just the hands. This means someone painting a room at home can develop a rash on the face, neck, or arms without ever having paint drip on them. The telltale sign is a dermatitis pattern on uncovered skin that appears during or shortly after painting and resolves once exposure stops.

Regulatory Landscape

The European Union has been the most aggressive regulator of isothiazolinones in consumer products, but most of that regulatory action has focused on MI and the MCI/MI combination rather than on BIT itself. After a wave of MI sensitization in the early 2010s, the EU’s Scientific Committee on Consumer Safety recommended banning MI from leave-on cosmetics and restricting it in rinse-off products. Those restrictions took effect in 2017 and appear to have reduced MI sensitization rates in subsequent years.

BIT, by contrast, has not yet been singled out for comparable restrictions in cosmetics at the EU level. It is regulated as a biocidal active substance under the EU Biocidal Products Regulation, which means its use in products like paints, adhesives, and industrial fluids is subject to approval and concentration limits. But there is growing pressure from dermatology groups to extend tighter controls to BIT, given the upward sensitization trend.

In the United States, the EPA regulates BIT as an antimicrobial pesticide, and the FDA oversees its use in cosmetics under the broader framework of cosmetic ingredient safety. There is no outright ban on BIT in US consumer products. The Cosmetic Ingredient Review panel has assessed isothiazolinones, but concentration limits are generally looser in the US than in Europe. For people with known BIT sensitivity, this means US products may contain it at levels that would not be permitted in some European markets.

What Happens to BIT in the Environment

Because BIT washes down drains from cleaning products and leaches from painted surfaces, its environmental fate matters. The good news is that BIT breaks down relatively quickly compared to many synthetic biocides. In water exposed to natural sunlight, its estimated half-life is roughly one day at mid-latitudes. Alkaline conditions speed up this breakdown further. However, while the parent compound degrades, some of its breakdown products still show chronic toxicity to aquatic organisms, which complicates the environmental picture.

BIT is also toxic to fish at moderate concentrations. A study found it was lethal to zebrafish embryos at concentrations in the low micromolar range, though treating the water with ozone rapidly destroyed BIT and eliminated the toxic effects.¹⁴ In soil, microbial communities play the primary role in breaking BIT down. The types of bacteria present and the soil’s organic matter content and pH significantly affect how quickly degradation occurs, with waterlogged soils sometimes speeding the process thanks to specific anaerobic bacteria.¹⁵

None of this means BIT is an environmental catastrophe. It degrades far faster than many persistent organic pollutants. But the combination of widespread use, moderate aquatic toxicity, and chronically toxic degradation products means it is not entirely benign once it leaves your sink or walls.

Making Sense of the Risk for Everyday Consumers

For someone without a known BIT allergy, the chemical at the concentrations found in well-formulated consumer products is unlikely to cause acute harm. You are not going to be poisoned by washing your dishes or painting a bedroom. The real risk is sensitization, and it is a one-way door: once your immune system decides BIT is an enemy, you are stuck avoiding it for life. Given that BIT appears in products across many categories, developing a sensitivity creates ongoing headaches in product selection.

To reduce your chances of sensitization, practical steps include wearing gloves when using BIT-containing cleaners or paints, ventilating rooms well during and after painting, and minimizing skin contact with freshly painted surfaces. If you develop unexplained eczema or a recurring rash, ask a dermatologist about patch testing that specifically includes BIT. Standard patch-test series vary by country, and BIT was not always included in baseline panels until recently, so you may need to request it.

The broader pattern here echoes what happened with MI: a preservative gets adopted widely as a replacement for a restricted predecessor, exposure climbs, and sensitization rates follow. Some dermatologists worry that BIT is simply repeating that cycle. The Belgian data showing sensitization rates peaking around 2019 and then declining offer a sliver of hope that awareness and possible reformulation may already be curbing the problem, but the trend data from other centers extending through 2023 suggest the wave has not crested everywhere.⁶

New Approaches to Reducing BIT Exposure

Researchers are not just documenting the problem; some are trying to engineer BIT into safer delivery formats. One approach involves encapsulating BIT inside ring-shaped sugar molecules called cyclodextrins. When BIT is locked inside the cavity of a modified cyclodextrin, it retains its ability to kill bacteria but is physically sequestered from direct skin contact until the coating it is embedded in slowly releases it. Lab studies have confirmed that BIT fits entirely inside the cyclodextrin cavity, with its active core oriented toward the wider end of the ring.¹⁶ The idea is that encapsulation could lower the free BIT concentration that contacts skin while still delivering enough antimicrobial activity to preserve a product. Whether this approach makes it into commercial products depends on cost and regulatory acceptance, but it represents a middle path between banning BIT and accepting rising sensitization rates.

A separate line of work has explored attaching BIT to polymer chains to create antimicrobial surface coatings that resist bacterial biofilm formation while minimizing the chance of bacteria developing resistance to BIT. The concept may sound niche, but biofilm prevention is relevant to everything from hospital equipment to marine coatings on ships, and reducing the amount of free BIT that enters waterways would be an environmental side benefit.